healthprotocol.wiki

bolanos-meade_2023_rct_ptcy-tac-mmf-vs-tac-mtx-gvhd-prophylaxis-allohct

5 findings

Protocol
therapy-post-transplant-cyclophosphamide-tacrolimus-mycophenolate-gvhd-prophylaxis-allogeneic-hct-reduced-intensity-conditioning-generic
Outcome
immune-gvhd-acute-incidence-measured
n
214
effect
45
attribution
85
Protocol
therapy-post-transplant-cyclophosphamide-tacrolimus-mycophenolate-gvhd-prophylaxis-allogeneic-hct-reduced-intensity-conditioning-generic
Outcome
immune-gvhd-chronic-incidence-cohort-measured
n
214
effect
45
attribution
85
Protocol
medication-gvhd-prophylaxis-tacrolimus-methotrexate-reduced-intensity-conditioning-generic
Outcome
survival-gvhd-free-relapse-free-at-1-year-proportion-cohort-measured
n
217
effect
0
attribution
85
Protocol
therapy-post-transplant-cyclophosphamide-tacrolimus-mycophenolate-gvhd-prophylaxis-allogeneic-hct-reduced-intensity-conditioning-generic
Outcome
survival-gvhd-free-relapse-free-at-1-year-proportion-cohort-measured
n
214
effect
55
attribution
85
Protocol
therapy-post-transplant-cyclophosphamide-tacrolimus-mycophenolate-gvhd-prophylaxis-allogeneic-hct-reduced-intensity-conditioning-generic
Outcome
survival-immunosuppression-free-at-1-year-proportion-cohort-measured
n
214
effect
45
attribution
85